AAO 2021: Teprotumumab Shown Effective for Mild Thyroid Eye Disease
The agent is the first and only prescription medication for the disorder.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
The agent is the first and only prescription medication for the disorder.
Only registered members have full access to PracticeUpdate content.